SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway

Cardiovascular Research

Volumn 104, Issue 1, 2014, Pages 83-92

  Gu, Jianmin ^a   Fan, Yuqi ^a   Liu, Xiaobing ^a   Zhou, Lihuang ^a   Cheng, Jinke ^a   Cai, Rong ^a   Xue, Song ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiac function; HIF1 ; Ischaemia reperfusion; SENP1

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEINASE; SUMO SPECIFIC PROTEASE 1; UNCLASSIFIED DRUG; HIF1A PROTEIN, HUMAN; HIF1A PROTEIN, MOUSE; HIF1A PROTEIN, RAT; SENP-1 PROTEIN, RAT; SENP1 PROTEIN, HUMAN; SENP1 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; FEMALE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; WILD TYPE; AGED; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEART CONTRACTION; HEART MUSCLE CELL; HEART STROKE VOLUME; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SUMOYLATION;

ADULT; AGED; ANIMALS; APOPTOSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOPEPTIDASES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTEIN STABILITY; SIGNAL TRANSDUCTION; STROKE VOLUME; SUMOYLATION; TRANSFECTION;

EID: 84913526848     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu177     Document Type: Article

References (37)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357: 1121-1135
2. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-460
3. Berthonneche C, Sulpice T, Boucher F, Gouraud L, de Leiris J, OConnor SE, Herbert JM, Janiak P.Newinsights into the pathological role of TNF-Alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats. Am J Physiol Heart Circ Physiol 2004; 287:H340-H350
4. Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I. Long-Term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 2004;43:295-301
5. Frank A, Bonney M, Bonney S, Weitzel L, Koeppen M, Eckle T. Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth 2012;16:123-132
6. Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J. Sirt1 protects the heart from ischemia/reperfusion. Circulation 2010; 122:2170-2182
7. Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ, Fan GC. MicroRNA-320 is involved in the regulationof cardiac ischemia/reperfusion injury by targeting Hsp20. Circulation 2009;119:2357-2366
8. Gill RS, Bigam DL, Cheung PY. The role of cyclosporine in the treatment of myocardial reperfusion injury. Shock 2012;37:341-347
9. Yeh ET. SUMOylation and De-SUMOylation: wrestling with lifes processes. J Biol Chem 2009;284:8223-8227
10. Mukhopadhyay D, Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sci 2007;32:286-295
11. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007;8:947-956
12. Gill G. Posttranslational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev 2003;13:108-113
13. Hay RT. SUMO: a history of modification. Mol Cell 2005;18:1-12
14. Muller S, Hoege C, Pyrowolakis G, Jentsch S. SUMO, ubiquitins mysterious cousin. Nat Rev Mol Cell Biol 2001;2:202-210
15. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503-533
16. Cheng J, Wang D, Wang Z, Yeh ET. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol 2004;24: 6021-6028
17. Li SJ, Hochstrasser M.Anewprotease required for cell-cycle progression in yeast. Nature 1999;398:246-251
18. Yeh ET, Gong L, Kamitani T. Ubiquitin-like proteins: new wines in new bottles. Gene 2000;248:1-14
19. Cheng J, Kang XL, Zhang S, Yeh ET. SUMO-specific protease l is essential for stabilization of HIFl a during hypoxia. Cell 2007;131:584-595
20. Song T, Zhang X, Wang C, Wu Y, Cai W, Gao J, Hong B. MiR-138 suppresses expression of hypoxia-inducible factor 1a (HIF-1a) in clear cell renal cell carcinoma 786-O cells. Asian Pac J Cancer Prev 2011;12:1307-1311
21. Tian H, Dai AG, Fu DY, Hu RC, ZhuLM. The expression and possible role ofSENP1 in the pulmonary vascular wall of rat during the development of hypoxic pulmonary hypertension. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2012;28:123-127
22. Bird SD, Doevendans PA, van Rooijen MA, Brutel de la Riviere A, Hassink RJ, Passier R, Mummery CL. The human adult cardiomyocyte phenotype. Cardiovasc Res 2003;58: 423-434
23. Depre C, Wang Q, Yan L, Hedhli N, Peter P, Chen L, Hong C, Hittinger L, Ghaleh B, Sadoshima J, Vatner DE, Vatner SF, Madura K. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 2006;114: 1821-1828
24. Peng T, Lu X, Lei M, Feng Q. Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-Alpha expression via cAMPmediated p38 MAPK pathway in cardiomyocytes. J Biol Chem 2003;278:8099-8105
25. Bunck AC, Engelen MA, Schnackenburg B, Furkert J, Bremer C, Heindel W, Stypmann J, Maintz D. Feasibility of functional cardiacMRimaging in mice using a clinical 3Tesla whole body scanner. Invest Radiol 2009;44:749-756
26. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU. Expression of hypoxia-inducible factor-1a and-2a in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002;13:1721-1732
27. Rosenberger C, Griethe W, Gruber G, Wiesener MS, Frei U, Bachmann S, Eckardt KU. Cellular responses to hypoxia after renal segmental infarction. Kidney Int 2003;64: 874-886
28. Xu Y, Li J, Zuo Y, Deng J, Wang LS, ChenGQ. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the up-regulated expression of CDK inhibitors. Cancer Lett 2011;309:78-84
29. Xu Y, Zuo Y, Zhang H, Kang X, Yue F, Yi Z, Liu M, Yeh ET, Chen G, Cheng J. Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis. J Biol Chem 2010;285:36682-36688
30. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000;45:651-660
31. Jiang Z, Fan Q, Zhang Z, Zou Y, Cai R, Wang Q, Zuo Y, Cheng J. SENP1 deficiency promotes ER stress-induced apoptosis by increasingXBP1SUMOylation. Cell Cycle 2012;11: 1118-1122
32. Loor G, Schumacker PT. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 2008;15:686-690
33. Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graça-Souza AV, Ollinger R, Czismadia E, May GA, Ifedigbo E, Otterbein LE, Bach FH, Soares MP. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 2004;18:771-772
34. Kang X, Li J, Zou Y, Yi J, Zhang H, Cao M, Yeh ET, Cheng J. PIASy stimulates HIF1a SUMOylation and negatively regulates HIF1a activity in response to hypoxia. Oncogene 2010;29:5568-5578
35. Ng SY, Wong CK, Tsang SY. Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. Am J Physiol Cell Physiol 2010;299:C1234-C1249
36. Zhou J, Hara K, Inoue M, Hamada S, Yasuda H, Moriyama H, Endo H, Hirota K, Yonezawa K, Nagata M, Yokono K. Regulation of hypoxia-inducible factor 1 by glucose availability under hypoxic conditions. Kobe J Med Sci 2008;53:283-296
37. Salvi S. Protecting the myocardium from ischemic injury: a critical role for a(1)-Adrenoreceptors?. Chest 2001;119:1242-1249